carisoprodol has been researched along with Acute Disease in 3 studies
Carisoprodol: A centrally acting skeletal muscle relaxant whose mechanism of action is not completely understood but may be related to its sedative actions. It is used as an adjunct in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1202)
carisoprodol : A carbamate ester that is the mono-N-isopropyl derivative of meprobamate (which is a significant metabolite). Carisoprodol interrupts neuronal communication within the reticular formation and spinal cord, resulting in sedation and alteration in pain perception. It is used as a muscle relaxant in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm.
Acute Disease: Disease having a short and relatively severe course.
Excerpt | Relevance | Reference |
---|---|---|
"The objective of this placebo-controlled trial was to determine the efficacy and safety of carisoprodol (Soma, MedPointe Pharmaceuticals, Somerset, NJ, USA), a centrally acting skeletal muscle relaxant used to treat acute, painful musculoskeletal conditions, at a dosage of 250 mg three times daily and at bedtime in patients with acute, painful muscle spasm of the lower back." | 9.13 | Double-blind, placebo-controlled trial of carisoprodol 250-mg tablets in the treatment of acute lower-back spasm. ( Look, M; Ralph, L; Sacks, H; Wheeler, W, 2008) |
"The objective of this placebo-controlled trial was to determine the efficacy and safety of carisoprodol (Soma, MedPointe Pharmaceuticals, Somerset, NJ, USA), a centrally acting skeletal muscle relaxant used to treat acute, painful musculoskeletal conditions, at a dosage of 250 mg three times daily and at bedtime in patients with acute, painful muscle spasm of the lower back." | 5.13 | Double-blind, placebo-controlled trial of carisoprodol 250-mg tablets in the treatment of acute lower-back spasm. ( Look, M; Ralph, L; Sacks, H; Wheeler, W, 2008) |
"Carisoprodol is a skeletal muscle relaxant with the potential for abuse." | 1.30 | A review of carisoprodol deaths in Jefferson County, Alabama. ( Alexander, CB; Davis, GG, 1998) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ralph, L | 1 |
Look, M | 1 |
Wheeler, W | 1 |
Sacks, H | 1 |
Middleton, RS | 1 |
Davis, GG | 1 |
Alexander, CB | 1 |
2 trials available for carisoprodol and Acute Disease
Article | Year |
---|---|
Double-blind, placebo-controlled trial of carisoprodol 250-mg tablets in the treatment of acute lower-back spasm.
Topics: Acute Disease; Adolescent; Adult; Aged; Carisoprodol; Disability Evaluation; Female; Humans; Low Bac | 2008 |
A comparison of two analgesic muscle relaxant combinations in acute back pain.
Topics: Acetaminophen; Acute Disease; Adolescent; Adult; Aged; Aspirin; Back Pain; Caffeine; Carisoprodol; C | 1984 |
1 other study available for carisoprodol and Acute Disease
Article | Year |
---|---|
A review of carisoprodol deaths in Jefferson County, Alabama.
Topics: Acute Disease; Adult; Alabama; Carisoprodol; Cause of Death; Coroners and Medical Examiners; Dextrop | 1998 |